Clinical trial

Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma

NCT01574729

Study summary

ClinicalTrials.gov

Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Surgery combined with rAd-p53 gene therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Surgery Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2012-08-01

PhasePHASE2

Conditions

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Interventions

Surgery combined with rAd-p53 gene therapyDRUG

SurgeryPROCEDURE

Sponsors & collaborators

Shenzhen SiBiono GeneTech Co.,Ltdlead sponsor

Mapped research locations

ChongqingChongqing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01574729 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.